Dr. Renzo Cecere is the Co-Founder, President, and CEO of Vitruvius Innovation Group and Venture Studio, a cutting-edge organization dedicated to transforming the landscape of healthcare innovation. With over 25 years of experience as a heart surgeon at McGill University, Dr. Cecere has earned a reputation for excellence in the field of cardiovascular surgery. His clinical expertise is complemented by a deep commitment to advancing medical research and healthcare technologies, focusing on novel therapies that address the most pressing challenges in heart disease treatment.

Dr. Cecere’s research centres on stem cell therapy for myocardial regeneration and the development of breakthrough therapies for end-stage heart disease. His work aims to translate scientific discoveries into practical, life-saving treatments for patients facing severe cardiac conditions. Through Vitruvius Innovation Group, he merges his extensive medical background with entrepreneurial vision, fostering a culture of innovation that accelerates the development of cutting-edge healthcare solutions. Dr. Cecere continues to lead the charge in bridging the gap between scientific research and clinical implementation, shaping the future of cardiovascular medicine.